---
title: "Stelara (ustekinumab) in plaque psoriasis: Real-world evidence questions"
description: "Real-world evidence questions on Stelara (ustekinumab) in plaque psoriasis, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: How many US adults with plaque psoriasis were treated with Stelara through 2019? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/real-world-evidence"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Stelara (ustekinumab) in plaque psoriasis: Real-world evidence questions

Manufacturer: Janssen Biotech, Inc.  
Prescribing information: [Stelara](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf)

Questions that apply to every indication of Stelara are on [Stelara (ustekinumab), all indications](https://www.evicenter.com/medical-information/stelara).

## Real-world evidence

<a id="stelara-patients-treated"></a>

### How many US adults with plaque psoriasis were treated with Stelara through 2019?

Applies to: Adults with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy

> “More than 300,000 adult patients with moderate to severe plaque psoriasis treated with STELARA<sup>®</sup> in the 
>
> United States<sup>1</sup> <sup>§</sup>”

Source: [STELARA: STELARA® (ustekinumab) for Plaque Psoriasis Treatment, captured 2026-11-13](https://www.stelarahcp.com/plaque-psoriasis/#:~:text=More%20than%20300%2C000%20adult%20patients,United)

> “<sup>§</sup>More than 300,000 adult patients treated with STELARA in the United States from September 2009 to December 2019. Estimations are based on calculations using product-utilization data collected in the United States for STELARA to determine patient type, average dose per administration, total number of administrations, and patient persistency rates.”

Source: [STELARA: STELARA® (ustekinumab) for Plaque Psoriasis Treatment, captured 2026-11-13](https://www.stelarahcp.com/plaque-psoriasis/#:~:text=than%20300%2C000%20adult%20patients%20treated,administrations%2C%20and%20patient%20persistency%20rates.)

## Related pages
- [Medical information: Stelara (ustekinumab): Plaque psoriasis](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis)
- [Indication](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/safety)
- [Specific populations](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis/storage-and-supply)
